InterVenn is a life sciences and technology company developing an AI-driven mass spectrometry platform. Its approach combines the analysis of glycoproteomics using mass spectrometry with data science and artificial intelligence to identify potentially actionable and clinically relevant information for conditions including cancers, autoimmunity, fibrosis, and neurodegeneration.
|HQ||South San Francisco, CA, US||Map|
|Employees (est.) (Jan 2021)||49||(+5%)|
InterVenn total Funding
InterVenn latest funding size
Time since last funding
|2 months ago|
|True Ventures, Amplify Partners, Boost VC, Xeraya Capital, PradoSV, Genoa Ventures|
When was InterVenn founded?
InterVenn was founded in 2017.
Who are InterVenn key executives?
InterVenn's key executives are Erwin Estigarribia, Aldo Carrascoso and Klaus Lindpaintner.
How many employees does InterVenn have?
InterVenn has 49 employees.
Who are InterVenn competitors?
Competitors of InterVenn include Berdac, Travecta Therapeutics and Unlearn.AI.
Where is InterVenn headquarters?
InterVenn headquarters is located at 2 Tower Pl 5th floor, South San Francisco.
Where are InterVenn offices?
InterVenn has offices in South San Francisco and Redwood City.
How many offices does InterVenn have?
InterVenn has 2 offices.
Receive alerts for 300+ data fields across thousands of companies